Your browser doesn't support javascript.
loading
Association of the kynurenine pathway metabolites with clinical, cognitive features and IL-1ß levels in patients with schizophrenia spectrum disorder and their siblings.
Noyan, Handan; Erdag, Ece; Tüzün, Erdem; Yaylim, Ilhan; Küçükhüseyin, Özlem; Hakan, Mehmet Tolgahan; Gülöksüz, Sinan; Rutten, Bart P F; Saka, Meram Can; Atbasoglu, Cem; Alptekin, Köksal; van Os, Jim; Üçok, Alp.
Afiliação
  • Noyan H; Department of Neuroscience, Aziz Sancar Institute of Experimental Medicine, Istanbul University, Istanbul, Turkey. Electronic address: handannoyan@gmail.com.
  • Erdag E; Department of Neuroscience, Aziz Sancar Institute of Experimental Medicine, Istanbul University, Istanbul, Turkey.
  • Tüzün E; Department of Neuroscience, Aziz Sancar Institute of Experimental Medicine, Istanbul University, Istanbul, Turkey.
  • Yaylim I; Department of Molecular Medicine, Aziz Sancar Institute of Experimental Medicine, Istanbul University, Istanbul, Turkey.
  • Küçükhüseyin Ö; Department of Molecular Medicine, Aziz Sancar Institute of Experimental Medicine, Istanbul University, Istanbul, Turkey.
  • Hakan MT; Department of Molecular Medicine, Aziz Sancar Institute of Experimental Medicine, Istanbul University, Istanbul, Turkey.
  • Gülöksüz S; Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht University Medical Center, Maastricht, the Netherlands. Electronic address: sinan.guloksuz@maastrichtuniversity.nl.
  • Rutten BPF; Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht University Medical Center, Maastricht, the Netherlands. Electronic address: b.rutten@maastrichtuniversity.nl.
  • Saka MC; Department of Psychiatry, School of Medicine, Ankara University, Ankara, Turkey.
  • Atbasoglu C; Department of Psychiatry, School of Medicine, Ankara University, Ankara, Turkey.
  • Alptekin K; Department of Psychiatry, Dokuz Eylul University School of Medicine, Izmir, Turkey. Electronic address: koksal.alptekin@deu.edu.tr.
  • van Os J; Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht University Medical Center, Maastricht, the Netherlands; Department of Psychiatry, UMC Utrecht Brain Center, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands; Department
  • Üçok A; Department of Psychiatry, Faculty of Medicine, Istanbul University, Istanbul, Turkey. Electronic address: alpucok@gmail.com.
Schizophr Res ; 229: 27-37, 2021 03.
Article em En | MEDLINE | ID: mdl-33609988
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Esquizofrenia / Cinurenina Tipo de estudo: Risk_factors_studies Limite: Humans Idioma: En Revista: Schizophr Res Assunto da revista: PSIQUIATRIA Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Esquizofrenia / Cinurenina Tipo de estudo: Risk_factors_studies Limite: Humans Idioma: En Revista: Schizophr Res Assunto da revista: PSIQUIATRIA Ano de publicação: 2021 Tipo de documento: Article